CD44 and breast carcinoma: Previously, we showed that the extracellular domains of EphA2 and CD44 can be displayed on the yeast cell surface and used to identify mAbs from a phage antibody library pre-selected on breast cancer cells overexpressing EphA2 and CD44 [23].